Saturday, August 30, 2014 Last update: 4:33 AM
FreshNews.com - All Company Technology News Since 1996

Quick-Med Technologies Announces Changes to Its Board of Directors

Companies mentioned in this article: Quick-Med Technologies, Inc.

GAINESVILLE, FL -- (Marketwire) -- 11/14/12 -- Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company developing novel antimicrobial technologies for healthcare and consumer markets, announced today the resignation of George E. Friel from the Company's Board of Directors, effective November 6, 2012. The Company also announced that its board has appointed John W. Sheets, Jr. to fill the vacancy resulting from General Friel's resignation.

"General Friel has been an invaluable and insightful director for the past twelve years. We will miss his leadership, expertise and wise counsel and we are grateful for his service," said Ladd Greeno, non-executive chairman of Quick-Med.

Major General George Friel, USA (Ret.) joined Quick-Med's board in July 2000. He resigned for personal reasons.

"We welcome John Sheets to the board and look forward to his contributions to the success of Quick-Med," said Bernd Liesenfeld, president of Quick-Med. "He will be an outstanding addition to provide direction for the future success of our company."

John Sheets has an extensive background in both research & development management and the healthcare industry. He is currently serving as Senior Vice President, Corporate Research, for Boston Scientific Corporation where he has established a renewed strategic direction for product and technology research activities while acting as an agent for change within the broader development organization to help advance Boston Scientific's corporate technology plan and strategy.

Prior to joining Boston Scientific, Dr. Sheets served as Corporate Vice President of Research & Development and Chief Technology Officer at Bausch & Lomb, leading the company's global research and development function for its Vision Care, Pharmaceutical and Surgical business units and directing efforts that led to 20 new product launches which grew the company's pipeline value by 140 percent. Previously, he served as CEO at HOYA Surgical Optics, Worldwide Vice President of R&D at Ethicon (a Johnson & Johnson company), and as Vice President of Surgical R&D at Alcon.

John Sheets earned Ph.D. and M.S. degrees in Materials Science and Engineering from the University of Florida, where he earlier earned a B.S. in Zoology. He also completed the Program for Management Development at Harvard Business School. He has been recognized as the inventor on 12 U.S. patents involving ophthalmic, bariatric and general surgery products. Dr. Sheets is also a 2012 inductee as a fellow into the American Institute for Medical and Biological Engineering (AIMBE).

About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. Stay Fresh®, Quick-Med's latest core-technology, joins NIMBUS®, used in wound dressings, and NimbuDerm™, a technology being developed as a long-lasting hand sanitizer. For more information, see: www.quickmedtech.com.

© 2012 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and Stay Fresh® are registered trademarks and NimbuDerm™ is a trademark of Quick-Med Technologies, Inc.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.


Contact:

CONTACT:
Quick-Med Technologies
Bernd Liesenfeld, Ph.D.
President
(888) 835.2211 Ext 103
Email Contact